Trial intelligence / Profile preview

Viscoat for wound closure in cataract surgery

NCT01298973Phase 4Completed

Sponsor
Janssen Pharmaceutical
Start
Jan 2011
Primary completion
Jan 2012
Modality
Polymer-based Nanoparticles, Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of sodium hyaluronate + chondroitin sulfate in cataract, sponsored by Janssen Pharmaceutical. Started Jan 2011; status: completed.

02

Drugs

sodium hyaluronate + chondroitin sulfate
03

Conditions

cataract

Beyond the preview

Go deeper on NCT01298973.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01298973.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call